RVTY
Revvity Inc
$117.50
0.38 (0.32%) Today
— up— down
Market Cap
$13.15B+29.2%
Revenue (TTM)
$2.91B+4.0%
Net Income (TTM)
$234.42M-10.8%
EPS (TTM)
2.10-10.8%
Shares Out
111.56M
111.56MP/E Ratio
55.10
55.10Forward P/E
20.29
20.29Dividend
$0.28 (0.24%)
$0.28 (0.24%)Ex-Dividend Date
Jul 17, 2026
Jul 17, 2026Open
$118.25
$118.25Previous Close
$117.88
$117.88Day Range
$115.67 – $118.34
$115.67 – $118.3452-Week Range
$81.22 – $118.34
$81.22 – $118.34Beta
1.08
1.08Volume
883.91K
883.91KAvg Volume
1.43M
1.43MExchange
NEW YORK STOCK EXCHANGE, INC.
NEW YORK STOCK EXCHANGE, INC.About RVTY
Revvity, Inc. is a multinational company headquartered in Waltham, Massachusetts, USA, in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines.
Related
News
N/AN/AN/AN/AN/A
Iran, US make competing claims over control of Strait of Hormuz - Reuters
Reuters · 2h ago
Hegseth says reports about poor conditions aboard carrier are misrepresented - Reuters
Reuters · 2h ago
EXCLUSIVE: Ukraine offers Russia truce in Black Sea as food supply fears mount, source says - Reuters
Reuters · 2h ago
Are global oil stocks big enough to weather another six months of US-Iran war? - Reuters
Reuters · 3h ago
US can keep naval blockade on Iranian ports "indefinitely," Pentagon chief says - Reuters
Reuters · 3h ago